Ginsenoside Rd

DB19256InvestigationalSmall molecule

Ginsenoside Rd is under investigation in clinical trial NCT00815763 (Efficacy and Safety of Ginsenoside-rd for Acute Ischemic Stroke).

Formula / weight: C₄₈H₈₂O₁₈ · 947.166 g/mol (avg)
Also known as: .beta.-d-glucopyranoside, (3.beta.,12.beta.)-20-(.beta.-d-glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl 2-o-.beta.-d-glucopyranosyl- · Chikusetsusaponin fk7 · Ginsenoside Rd (constituent of american ginseng, asian ginseng, and tienchi ginseng) · Gypenoside viii

Resolves to

Compound

UNIIWB232T95AVCAS52705-93-8ChEMBLCHEMBL473659ChEBI67988

Structure

InChIKeyRLDVZILFNVRJTL-IWFVLDDISA-NSMILES

[H][C@@]1(CC[C@]2(C)[C@]1([H])[C@H](O)C[C@]1([H])[C@@]3(C)CC[C@H](O[C@]4([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@]4([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@]3([H])CC[C@@]21C)[C@](C)(CCC=C(C)C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O

What you can answer from here — as of July 11, 2026

2Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which companies are running trials of Ginsenoside Rd, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account